AstraZeneca Admits Flaws In Its Vaccine, Will It Pay On The Stock Market?

The pharmaceutical company AstraZeneca and the University of Oxford have revealed errors in the manufacture and administration of the doses of their vaccine against COVID-19 and, therefore, doubts surrounding their effectiveness.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.